drugset / Trial / NCT03317795
Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids
Phase 4
Completed
18 enrolled
Shannon K. Laughlin-Tommaso
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized controlled trial (RCT) to assess the comparative effectiveness of Levonorgestrel Intrauterine System (LNG-IUS) to Tranexamic Acid (TA) for the treatment of heavy menstrual bleeding (HMB) in women with clinically-significant fibroids.
Timeline
- Start
- 2017-11-14
- Primary completion
- 2020-12-28
- Completion
- 2020-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levonorgestrel | Small molecule | 52 mg | Other |
| Comparator | Tranexamic Acid | Small molecule | 1300 mg | Oral |